206548-14-3

Basic information

• Product Name: METHYL 2-AMINO-5-BROMO-3-METHYLBENZENECARBOXYLATE
• Synonyms: METHYL 2-AMINO-5-BROMO-3-METHYLBENZENECARBOXYLATE;2-Amino-5-bromo-3-methylbenzoic acid methyl ester;Methyl 2-amino-5-bromo-3-methylbenzoate;Methyl 2-amino-5-bromo-m-toluate, Methyl 5-bromo-3-methylanthranilate;Benzoic acid, 2-aMino-5-broMo-3-Methyl-, Methyl ester
• CAS NO: 206548-14-3
• Molecular Formula: C₉H₁₀BrNO₂
• Molecular Weight: 244.09
• Mol File: 206548-14-3.mol
• Article Data: 18

Chemical Properties

• Melting Point: 56-58
• Boiling Point: 307.3±37.0 °C(Predicted)
• Appearance: /
• Density: 1.506
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 1.61±0.10(Predicted)
• CAS DataBase Reference: METHYL 2-AMINO-5-BROMO-3-METHYLBENZENECARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2-AMINO-5-BROMO-3-METHYLBENZENECARBOXYLATE(206548-14-3)
• EPA Substance Registry System: METHYL 2-AMINO-5-BROMO-3-METHYLBENZENECARBOXYLATE(206548-14-3)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 206548-14-3(Hazardous Substances Data)

Usage

General Description

Methyl 2-amino-5-bromo-3-methylbenzenecarboxylate, also known as CAS No. 70274-51-4, is an organic chemical compound belonging to the class of organic compounds known as benzoic acid esters. Its molecular formula is C9H10BrNO2. It is characterized by the presence of a bromo substituent along with two methyl groups attached to different positions of a benzene ring. It has a role as a synthetic compound used for chemical synthesis and research purposes. Its other properties, such as solubility, stability, melting and boiling points, may vary according to environmental conditions and purity of the sample. Chemical handling and disposal should be done according to prescribed regulations due to its potential hazards.

Upstream product

• 22223-49-0 methyl 2-amino-3-methylbenzoate 
• 206548-13-2 2-amino-5-bromo-3-methylbenzoic acid 
• 74-88-4 methyl iodide 
• 4389-45-1 3-methylantranilic acid 
• 67-56-1 methanol 
• 5471-82-9 methyl 3-methyl-2-nitrobenzoate 

Downstream Products

• 206546-94-3 5-bromo-2-(4-methoxy-benzenesulfonylamino)-3-methyl-benzoic acid methyl ester 
• 785818-24-8 2-amino-3,4-dihydro-4-oxo-8-[(phenylsulfanyl)methyl]quinazoline-6-carbonitrile 
• 785818-01-1 N-[6-bromo-3,4-dihydro-4-oxo-8-(phenoxymethyl)quinazolin-2-yl]-2,2-dimethylpropanamide 
• 785818-08-8 N-[3,4-dihydro-6-hydroxy-4-oxo-8-(phenoxymethyl)quinazolin-2-yl]-2,2-dimethylpropanamide 
• 785818-03-3 N-{6-bromo-3,4-dihydro-4-oxo-8-[(phenylsulfanyl)methyl]quinazolin-2-yl}-2,2-dimethylpropanamide 
• 785818-22-6 N-{6-cyano-3,4-dihydro-4-oxo-8-[(phenylsulfanyl)methyl]quinazolin-2-yl}-2,2-dimethylpropanamide 
• 785818-16-8 N-{6-{[(tert-butyl)dimethylsilyl]oxy}-3,4-dihydro-4-oxo-8-[(phenylsulfanyl)methyl]quinazolin-2-yl}-2,2-dimethylpropanamide 
• 287108-60-5 5-bromo-2-[(4-hydroxy-benzenesulfonyl)-methyl-amino]-3-methyl-benzoic acid methyl ester 
• 287108-58-1 5-bromo-2-[(4-fluoro-benzenesulfonyl)-methyl-amino]-3-methyl-benzoic acid methyl ester 
• 287108-61-6 5-bromo-3-methyl-2-[methyl-(4-prop-2-ynyloxy-benzenesulfonyl)-amino]-benzoic acid methyl ester 
• 287109-12-0 5-bromo-3-methyl-2-[methyl-(4-prop-2-ynyloxy-benzenesulfonyl)-amino]-benzoic acid 
• 287108-97-8 5-bromo-2-[(4-butoxy-benzenesulfonyl)-methyl-amino]-3-methyl-benzoic acid 
• 287108-62-7 5-bromo-2-[(4-but-2-ynyloxy-benzenesulfonyl)-methyl-amino]-3-methyl-benzoic acid 
• 287108-96-7 5-bromo-2-[(4-butoxy-benzenesulfonyl)-methyl-amino]-3-methyl-benzoic acid methyl ester 

Relevant articles and documents

Rational design of selective inhibitors of PARP4

PARPs (PARP1-16 in humans) are a large family of ADP-ribosyltransferases (ARTs) that have diverse roles in cellular physiology and pathophysiology. Most PARP family members mediate mono-ADP-ribosylation (MARylation) of targets. The function of PARP-mediated MARylation in cells is poorly characterized, due in large part to the paucity of selective small molecule inhibitors of the catalytic activity of individual PARP enzymes. Herein we describe the rational design of selective small molecule inhibitors of PARP4 (also known as vPARP). These inhibitors are based on a quinazolin-4(3H)-one scaffold, and contain substituents at the C-8 position designed to exploit a unique threonine (Thr484, human PARP4 numbering) in the PARP4 nicotinamide sub-pocket. Our most potent analog, AEP07, which contains an iodine at the C-8 position, is at least 12-fold selective over other PARP family members. AEP07 will serve as a useful lead compound for the further development of PARP4 inhibitors that can be used to probe the cellular functions of PARP4 catalytic activity. This journal is

ARYL, HETEROARY, AND HETEROCYCLIC PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS

Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, and Formula V, or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.

POLYSUBSTITUTED PYRIDYL PYRAZOLECARBOXAMIDE AND PREPARATION METHOD AND USE THEREOF

The present invention discloses a polysubstituted pyridyl pyrazolecarboxamide and its preparation method and use. The structure of the polysubstituted pyridyl pyrazolecarboxamide of the present invention is shown in the following General Formula I. The po